Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | SCN4A | P35499 | 2/20 | 0.44 |
| ▸ | CFTR | P13569 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | AOC2 | O75106 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.40 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4523648 | 0.81 | ALDH1A1 (0.47) | KDM4ECYP1A2SCN4AALDH1A1GLA | |
| SCHEMBL1710062 | 0.80 | CYP1A2 (0.47) | KDM4ECYP1A2SCN4AALDH1A1GLA | |
| SCHEMBL17815773 | 0.79 | SMN1; SMN2 (0.41) | KDM4EALDH1A1MEN1KMT2ANPSR1 | |
| SCHEMBL18353950 | 0.79 | MAPT (0.44) | KDM4ECYP1A2CFTRALDH1A1MEN1 | |
| SCHEMBL16773945 | 0.79 | CFTR (0.40) | KDM4ECFTRALDH1A1MEN1KMT2A | |
| SCHEMBL28080949 | 0.77 | SSTR4 (0.42) | KDM4ECYP1A2CFTRALDH1A1MEN1 | |
| SCHEMBL17811834 | 0.76 | HTT (0.37) | KDM4EALDH1A1MEN1KMT2ANPSR1 | |
| SCHEMBL8083251 | 0.75 | ALDH1A1 (0.48) | KDM4ECYP1A2SCN4AALDH1A1GLA | |
| SCHEMBL16757673 | 0.75 | NPSR1 (0.39) | KDM4ECFTRALDH1A1MEN1KMT2A | |
| SCHEMBL8468869 | 0.75 | CFTR (0.37) | KDM4ECFTRALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11693310-B2 | Blue curable resin composition, blue color filter, and display device including same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-07-04 | — | — | US | disclosed |
| US-11209733-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-28 | — | — | US | disclosed |
| US-11209734-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-28 | — | — | US | disclosed |
| US-11204554-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-21 | — | — | US | disclosed |
| US-20200199261-A1 | HIGHLY SENSITIVE OXIME ESTER PHOTOPOLYMERIZATION INITIATOR AND PHOTOPOLYMERIZABLE COMPOSITION INCLUDING THE SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2020-06-25 | — | — | US | disclosed |
| US-10488756-B2 | Oxime ester photoinitiators | BASF SE (DE) | 2019-11-26 | — | — | US | disclosed |
| EP-3354641-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2019-07-17 | — | — | EP | disclosed |
| EP-2847167-B9 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2019-02-20 | — | — | EP | disclosed |
| EP-2847167-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2018-07-18 | — | — | EP | disclosed |
| EP-2963015-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2018-07-11 | — | — | EP | disclosed |
| US-9051397-B2 | Oxime ester | BASF SE (DE) | 2015-06-09 | — | — | US | disclosed |
| WO-2015080503-A1 | PHOTOINITIATOR AND PHOTOSENSITIVE COMPOSITION INCLUDING THE SAME | TAKOMA TECHNOLOGY CO., LTD. (KR) | 2015-06-04 | — | — | WO | disclosed |
| US-20150064624-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2015-03-05 | — | — | US | disclosed |
| US-20150064624-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2015-03-05 | — | — | US | disclosed |
| EP-2625166-B1 | OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS | BASF SE (DE) | 2014-09-24 | — | — | EP | disclosed |
| US-20130188270-A1 | OXIME ESTER | BASF SE (DE) | 2013-07-25 | — | — | US | disclosed |
| US-20130188270-A1 | OXIME ESTER | BASF SE (DE) | 2013-07-25 | — | — | US | disclosed |
| WO-2012045736-A1 | OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS | BASF SE (DE) | 2012-04-12 | — | — | WO | disclosed |
| US-20070219216-A1 | 1-Alkylpiperazinyl-Pyrrolidin-2,5-Dione Derivatives as Adrenergic Receptor Antagonists | RANBAXY LABORATORIES LIMITED (IN) | 2007-09-20 | — | — | US | disclosed |
| US-20070219216-A1 | 1-Alkylpiperazinyl-Pyrrolidin-2,5-Dione Derivatives as Adrenergic Receptor Antagonists | RANBAXY LABORATORIES LIMITED (IN) | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11209734-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | KDM4E 1549/4885CYP1A2 48/4885SCN4A 1022/4885 |
| US-10488756-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | KDM4E 1549/4885CYP1A2 48/4885SCN4A 1022/4885 |
| US-11204554-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | KDM4E 1583/4885CYP1A2 44/4885SCN4A 1086/4885 |
| US-20130188270-A1 | OXIME ESTER | CBR3, CBR1, COX15 | KDM4E 2194/4885CYP1A2 103/4885SCN4A 1248/4885 |
| US-20070219216-A1 | 1-Alkylpiperazinyl-Pyrrolidin-2,5-Dione Derivatives as Adrenergic Receptor Antagonists | ADRA1D, ADRA1A, ADRB1 | KDM4E 3759/4885CYP1A2 184/4885SCN4A 1644/4885 |
| US-20200199261-A1 | HIGHLY SENSITIVE OXIME ESTER PHOTOPOLYMERIZATION INITIATOR AND PHOTOPOLYMERIZABLE COMPOSITION INCLUDING THE SAME | LCLAT1, LPO, PLOD2 | KDM4E 74/4885CYP1A2 248/4885SCN4A 3911/4885 |
| US-11209733-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | KDM4E 1549/4885CYP1A2 48/4885SCN4A 1022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.